Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
1.42
Jul. 11, 2025 16:00:00- Change 0.04 (2.89855%)
- Volume 668,411
- Today's Open 1.4
- Previous Close 1.38
- Today's High 1.455
- Today's Low 1.35
- 52 Week High 4.3
- 52 Week Low 0.85